The Great Masquerader: Mycotoxins

Mycotoxins are toxic secondary metabolites produced by mold that can cause a wide range of diseases in humans. The World Health Organization has designated mycotoxin-related illness as “the Great Masquerader” of the 21st century due to its ability to present with nonspecific clinical signs and symptoms across multiple organ systems that are not routinely suspected by clinicians. Patients affected by mycotoxins may be misdiagnosed with chronic Lyme disease, chronic fatigue syndrome, fibromyalgia, autoimmune disorders, and psychiatric conditions. This paper reviews the nature of mold and mycotoxin exposure, mechanisms of toxicity, and the broad spectrum of adverse health effects ranging from acute toxicity to long-term consequences including autism, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, mast cell activation syndrome, inflammatory bowel diseases, immune dysregulation, and cancers. The paper discusses evidence-based approaches to diagnosis including blood serum antibody testing, the limitations of urine-based mycotoxin testing, and a treatment paradigm encompassing environmental remediation, antifungal therapy, nutritional support, immune system restoration, and gut healing. The importance of including molds and mycotoxins in the clinician’s differential diagnosis is emphasized.